The team assessed the influence of KAT6A energy on the expression of PIK3CA in glioma cells, and the result indicated that it effectively inhibited the expression of PIK3CA and the activation of the PIEK/AKT signaling pathway. Here, KAT6A is linked to central nervous system cancer.